Labcorp Holdings Inc. (LH) Guidance & Earnings Results

On 2026-07-30 Labcorp Holdings Inc. raised guidance: "Full-year 2026 revenue growth guidance raised to 5.4%-6.3%, adjusted EPS to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LHLabcorp Holdings Inc.Follow LH — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 26.7B
P/E TTM: 27.2
Dividend yield: 0.9%
52-week: —
Next earnings: 28 Oct, in 4 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
30 Jul 26	Raised	Full-year 2026 revenue growth guidance raised to 5.4%-6.3%, adjusted EPS to $18.10-$18.55 · full year
30 Apr 26	Raised	FY2026 adj. EPS guidance raised $0.13 to $18.03 midpoint; revenue guidance up 20 bps to 5.0-6.1%. · full year
17 Feb 26	Raised	FY2026 revenue $14.61-14.79B (+5.4% midpoint), adj. EPS $17.55-18.25 (+8.9%), FCF $1.24-1.36B (+7.8%) · full year
28 Oct 25	Mixed	Revenue guidance lowered 40bps; adjusted EPS midpoint raised $0.05; FCF midpoint raised $25M · full year
24 Jul 25	Raised	FY25 enterprise revenue growth raised to 7.5%-8.6% from 6.7%-8.0%; adjusted EPS raised to $16.05-$16.50 from $15.70-$16.40; free cash flow raised to $1.13B-$1.28B from $1.10B-$1.25B; Diagnostics revenue growth raised to 7.0%-8.0% from 6.5%-7.7%; Biopharma revenue growth raised to 6.1%-7.5% from 3.0%-5.0%. · full year

Labcorp Holdings Inc. — questions

What guidance did Labcorp Holdings Inc. give?: On 2026-07-30: "Full-year 2026 revenue growth guidance raised to 5.4%-6.3%, adjusted EPS to $18.10-$18.55"
When does Labcorp Holdings Inc. report earnings?: Labcorp Holdings Inc.'s next earnings report is expected on 2026-10-28.

Every figure on this page comes from Labcorp Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.